NLRP3 and Parkinson disease: Since activation of the microglial NLRP3 inflammasome was verified to play a pivotal role in the progression of neurodegenerative disorders, such as AD, PD, and ALS, inhibition of NLRP3 inflammasome activation might become a promising therapeutic target for these neurodegenerative disorders.